Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density

被引:174
作者
vanDijke, CF
Brasch, RC
Roberts, TPL
Weidner, N
Mathur, A
Shames, DM
Mann, JS
Demsar, F
Lang, P
Schwickert, HC
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT RADIOL,CONTRAST MEDIUM LAB,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT SURG PATHOL,SAN FRANCISCO,CA 94143
关键词
breast neoplasms; MR; gadolinium; magnetic resonance (MR); contrast enhancement; neoplasms; blood supply;
D O I
10.1148/radiology.198.3.8628876
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine the relationship between capillary density, a recognized surrogate of tumor angiogenesis, and magnetic resonance (MR) imaging-derived estimates of plasma volume (PV) and microvascular permeability in two mammary carcinoma models. MATERIALS AND METHODS: Dynamic spin-echo imaging was performed by using albumin-(gadolinium-diethylenetriaminepentaacetic acid)(34), a prototype blood-pool contrast medium, in 14 rats with a subcutaneously implanted slow- or fast-growing subtype of R3230 mammary carcinoma. Data were fitted to an established two-compartment kinetic model to estimate PV and permeability. RESULTS: MR imaging-derived tumor PVs and permeabilities increased exponentially with increasing capillary density. MR imaging-derived microvascular characteristics correlated strongly with histologic capillary density, with an r(2) of .85. CONCLUSION: Contrast medium-enhanced MR imaging may prove useful in estimating angiogenic activity in carcinomas. MR imaging may be superior to histologic assay because it is noninvasive, can be used to ''sample'' the entire tumor, and reflects both anatomic and physiologic characteristics.
引用
收藏
页码:813 / 818
页数:6
相关论文
共 39 条
[1]  
ACKERMAN NB, 1978, SURG GYNECOL OBSTET, V146, P884
[2]  
BOGDEN A, 1989, BREAST CANCER, P283
[3]   MICROVESSEL QUANTITATION AND PROGNOSIS IN INVASIVE BREAST-CARCINOMA [J].
BOSARI, S ;
LEE, AKC ;
DELELLIS, RA ;
WILEY, BD ;
HEATLEY, GJ ;
SILVERMAN, ML .
HUMAN PATHOLOGY, 1992, 23 (07) :755-761
[4]  
BRASCH R, 1991, WORKSHOP CONTRAST EN, P163
[5]  
BREM S, 1972, J NATL CANCER I, V48, P347
[6]  
COHEN F, 1995, INVEST RADIOL, V29, P970
[7]   PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF INDICATOR DIFFUSION METHOD [J].
CRONE, C .
ACTA PHYSIOLOGICA SCANDINAVICA, 1963, 58 (04) :292-&
[8]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[9]   DISTRIBUTION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN TUMORS - CONCENTRATION IN TUMOR BLOOD-VESSELS [J].
DVORAK, HF ;
SIOUSSAT, TM ;
BROWN, LF ;
BERSE, B ;
NAGY, JA ;
SOTREL, A ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1275-1278
[10]  
DVORAK HF, 1988, AM J PATHOL, V133, P95